Evaluation of Primary Plating in Sternotomy Patients for Osteosynthesis and Pain

NCT ID: NCT00819286

Last Updated: 2018-02-13

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-11-30

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to evaluate sternal osteosynthesis, chest wall pain and return to normal activity in open heart surgery patients who had their breast bone closed either with wires or plates.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Median sternotomy patients will be randomized to either wire or rigid fixation groups. A scheduled evaluation period will record clinical parameters. Enrollment has ended with one hundred forty (140) patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sternal Wound Infection Sternal Non-union Pain Mediastinitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Participant blinded to treatment assignment until completion of study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

wire (control)

patients will have their sternum closed using wire (stainless steel surgical wire).

Group Type ACTIVE_COMPARATOR

wire (control)

Intervention Type DEVICE

patients will have their sternum closed using wire (stainless steel surgical wire).

SternaLock Rigid Fixation Plates

patients will have their sternum closed by rigid fixation using SternaLock Rigid Fixation Plates.

Group Type EXPERIMENTAL

SternaLock Rigid Fixation Plates

Intervention Type DEVICE

patients will have their sternum closed by rigid fixation using SternaLock Rigid Fixation Plates

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SternaLock Rigid Fixation Plates

patients will have their sternum closed by rigid fixation using SternaLock Rigid Fixation Plates

Intervention Type DEVICE

wire (control)

patients will have their sternum closed using wire (stainless steel surgical wire).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing median sternotomy;
* Patients eighteen (18) years of age or older;
* Patients presenting two or more risk factors such as diabetes mellitus, Chronic Obstructive Pulmonary Disease, obesity (BMI \> 30), osteoporosis, Renal failure, Chronic steroid use, Immunosuppression, Redo sternotomy, Neurologic dysfunction severely affecting ambulation,
* Off mid-line sternotomy
* bilateral IMA use
* Long cardio-pulmonary bypass runs
* Transverse fractures of the sternum

Exclusion Criteria

* Patients with a non-standard sternotomy;
* Patients with an off-midline sternotomy that reduced the bony margin to \<2mm
* Patients under eighteen (18) years of age;
* Patients that are pregnant or currently lactating;
* Patients presenting intra-operative conditions that would require the use of rigid fixation and/or additional post-sternotomy mechanical support beyond wire cerclage due to surgical evaluation,
* Patients defined within the New York Heart Association (NYHA) or Canadian Cardiovascular Society (CCS) functional Class IV for congestive heart failure,
* Patients presenting emergent/salvage cardiac acuity as defined per the Society of Thoracic Surgeons (STS) guidelines: i.e., patients undergoing cardiopulmonary resuscitation en route to the operating room or prior to induction of anesthesia;
* Patients undergoing post-operative revision procedures that treat the original sternotomy in such a way as to affect outcome (antibiotic irrigation, debridement or other treatment to the osteotomy);
* Patients unwilling or unable to return for follow-up;
* Lacking the ability to follow instructions;
* Intraoperative death.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zimmer Biomet

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jai Raman, MD

Role: STUDY_CHAIR

University of Chicago

Michael Wong, MD

Role: PRINCIPAL_INVESTIGATOR

University of California Davis Medical Center, Sacramento, CA

Brian DeGuzmann, MD

Role: PRINCIPAL_INVESTIGATOR

St. Joseph's Medical Center, Phoenix, AZ

Sven Lehmann, MD

Role: PRINCIPAL_INVESTIGATOR

Leipzig Heart Center, Leipzig, Germany

Kenton Zehr, MD

Role: PRINCIPAL_INVESTIGATOR

Scott & White Memorial Hospital, Temple, TX

H Edward Garrett, Jr, MD

Role: PRINCIPAL_INVESTIGATOR

Baptist Memorial Hospital, Memphis, TN

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Joseph's Heart and Lung Institute

Phoenix, Arizona, United States

Site Status

University of California Davis Medical Center

Sacramento, California, United States

Site Status

University of Chicago

Chicago, Illinois, United States

Site Status

Baptist Memorial Hospital

Memphis, Tennessee, United States

Site Status

Scott & White Memorial Hospital

Temple, Texas, United States

Site Status

Leipzig Heart Center

Leipzig, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

07071

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Adaptix RCT Evaluating Adaptix™ Versus PEEK Cages
NCT05182489 ACTIVE_NOT_RECRUITING NA
Slotted Hole Versus Fixed Hole C-Tek
NCT00585923 TERMINATED NA